| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.23B | 3.09B | 2.75B | 2.66B | 2.71B |
| Gross Profit | 2.60B | 1.31B | 1.10B | 1.03B | 1.06B |
| EBITDA | 998.52M | 987.68M | 830.30M | 780.07M | 703.98M |
| Net Income | 751.23M | 470.52M | 576.60M | 472.07M | 477.36M |
Balance Sheet | |||||
| Total Assets | 15.01B | 14.58B | 15.03B | 14.64B | 16.12B |
| Cash, Cash Equivalents and Short-Term Investments | 4.02B | 1.68B | 1.62B | 3.05B | 3.18B |
| Total Debt | 1.87B | 1.95B | 2.04B | 2.08B | 2.04B |
| Total Liabilities | 12.57B | 12.32B | 12.96B | 12.61B | 14.03B |
| Stockholders Equity | 2.45B | 2.26B | 2.07B | 2.03B | 2.08B |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 832.86M | 658.62M | 731.86M | 632.27M |
| Operating Cash Flow | 0.00 | 862.09M | 692.52M | 757.66M | 656.96M |
| Investing Cash Flow | 0.00 | -232.25M | -90.05M | -200.05M | -923.38M |
| Financing Cash Flow | 0.00 | -551.14M | -479.62M | -457.85M | 107.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $3.88B | 8.60 | 6.05% | 2.91% | -4.58% | ― | |
72 Outperform | $8.29B | 11.34 | 31.86% | 1.59% | 5.63% | 67.39% | |
72 Outperform | $7.95B | -336.71 | 0.27% | 2.98% | 24.94% | ― | |
70 Outperform | $11.43B | 10.21 | ― | 0.74% | 3.73% | 17.47% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $7.95B | 7.17 | 12.27% | 3.93% | 35.76% | 636.97% | |
63 Neutral | $12.00B | 17.15 | 6.69% | 2.22% | 1.80% | -44.44% |
On November 5, 2025, Primerica, Inc. reported its financial results for the third quarter of 2025, highlighting record sales in investment and savings products and a significant increase in client asset values. The company saw an 8% rise in total revenues and a 6% increase in net income compared to the same period in 2024. Despite a decline in new life insurance policies issued, Primerica’s term life segment showed steady growth in premiums. The company also completed its annual actuarial assumption review, resulting in a net remeasurement gain. These results underscore the strength of Primerica’s business model and its commitment to supporting middle-income families.
The most recent analyst rating on (PRI) stock is a Buy with a $340.00 price target. To see the full list of analyst forecasts on Primerica stock, see the PRI Stock Forecast page.